Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.63 CAD -6.92% Market Closed
Market Cap: 99.5m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Intrinsic Value

The intrinsic value of one COV stock under the Base Case scenario is 1.64 CAD. Compared to the current market price of 3.63 CAD, Covalon Technologies Ltd is Overvalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

COV Intrinsic Value
1.64 CAD
Overvaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Covalon Technologies Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for COV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about COV?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Covalon Technologies Ltd

Provide an overview of the primary business activities
of Covalon Technologies Ltd.

What unique competitive advantages
does Covalon Technologies Ltd hold over its rivals?

What risks and challenges
does Covalon Technologies Ltd face in the near future?

Summarize the latest earnings call
of Covalon Technologies Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Covalon Technologies Ltd.

Provide P/S
for Covalon Technologies Ltd.

Provide P/E
for Covalon Technologies Ltd.

Provide P/OCF
for Covalon Technologies Ltd.

Provide P/FCFE
for Covalon Technologies Ltd.

Provide P/B
for Covalon Technologies Ltd.

Provide EV/S
for Covalon Technologies Ltd.

Provide EV/GP
for Covalon Technologies Ltd.

Provide EV/EBITDA
for Covalon Technologies Ltd.

Provide EV/EBIT
for Covalon Technologies Ltd.

Provide EV/OCF
for Covalon Technologies Ltd.

Provide EV/FCFF
for Covalon Technologies Ltd.

Provide EV/IC
for Covalon Technologies Ltd.

Show me price targets
for Covalon Technologies Ltd made by professional analysts.

What are the Revenue projections
for Covalon Technologies Ltd?

How accurate were the past Revenue estimates
for Covalon Technologies Ltd?

What are the Net Income projections
for Covalon Technologies Ltd?

How accurate were the past Net Income estimates
for Covalon Technologies Ltd?

What are the EPS projections
for Covalon Technologies Ltd?

How accurate were the past EPS estimates
for Covalon Technologies Ltd?

What are the EBIT projections
for Covalon Technologies Ltd?

How accurate were the past EBIT estimates
for Covalon Technologies Ltd?

Compare the revenue forecasts
for Covalon Technologies Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Covalon Technologies Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Covalon Technologies Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Covalon Technologies Ltd compared to its peers.

Compare the P/E ratios
of Covalon Technologies Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Covalon Technologies Ltd with its peers.

Analyze the financial leverage
of Covalon Technologies Ltd compared to its main competitors.

Show all profitability ratios
for Covalon Technologies Ltd.

Provide ROE
for Covalon Technologies Ltd.

Provide ROA
for Covalon Technologies Ltd.

Provide ROIC
for Covalon Technologies Ltd.

Provide ROCE
for Covalon Technologies Ltd.

Provide Gross Margin
for Covalon Technologies Ltd.

Provide Operating Margin
for Covalon Technologies Ltd.

Provide Net Margin
for Covalon Technologies Ltd.

Provide FCF Margin
for Covalon Technologies Ltd.

Show all solvency ratios
for Covalon Technologies Ltd.

Provide D/E Ratio
for Covalon Technologies Ltd.

Provide D/A Ratio
for Covalon Technologies Ltd.

Provide Interest Coverage Ratio
for Covalon Technologies Ltd.

Provide Altman Z-Score Ratio
for Covalon Technologies Ltd.

Provide Quick Ratio
for Covalon Technologies Ltd.

Provide Current Ratio
for Covalon Technologies Ltd.

Provide Cash Ratio
for Covalon Technologies Ltd.

What is the historical Revenue growth
over the last 5 years for Covalon Technologies Ltd?

What is the historical Net Income growth
over the last 5 years for Covalon Technologies Ltd?

What is the current Free Cash Flow
of Covalon Technologies Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Covalon Technologies Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Covalon Technologies Ltd

Current Assets 23.3m
Cash & Short-Term Investments 9.4m
Receivables 6.3m
Other Current Assets 7.5m
Non-Current Assets 3.3m
PP&E 1.4m
Intangibles 1.5m
Other Non-Current Assets 458.6k
Current Liabilities 4.4m
Accounts Payable 3.8m
Other Current Liabilities 669.8k
Non-Current Liabilities 417.2k
Long-Term Debt 412.7k
Other Non-Current Liabilities 4.5k
Efficiency

Earnings Waterfall
Covalon Technologies Ltd

Revenue
29.2m CAD
Cost of Revenue
-12.7m CAD
Gross Profit
16.5m CAD
Operating Expenses
-17.9m CAD
Operating Income
-1.4m CAD
Other Expenses
553.2k CAD
Net Income
-823.4k CAD

Free Cash Flow Analysis
Covalon Technologies Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Covalon reported a significant turnaround in its Q3 financials, achieving a 47% revenue growth to $9.2 million and a gross margin of 59%. Adjusted EBITDA improved by $2.8 million, reaching $2.4 million from a $400,000 loss the previous year. Earnings per share grew to $0.06 from a $0.02 loss. The U.S. market drove most of the success, representing 87% of total revenue, with a notable increase in product revenue by 52.6%. The company's strategic cost management reduced operating expenses by $236,000, leading to overall profitability. Covalon aims for continued growth in Q4 and beyond, focusing heavily on the U.S. market and operational efficiency.

What is Earnings Call?
Fundamental Scores

COV Profitability Score
Profitability Due Diligence

Covalon Technologies Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive 1-Year Revenue Growth
40/100
Profitability
Score

Covalon Technologies Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

COV Solvency Score
Solvency Due Diligence

Covalon Technologies Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Covalon Technologies Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COV Price Targets Summary
Covalon Technologies Ltd

There are no price targets for COV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for COV?

Click here to dive deeper.

Dividends

Covalon Technologies Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for COV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Covalon Technologies Ltd Logo
Covalon Technologies Ltd

Country

Canada

Industry

Biotechnology

Market Cap

99.5m CAD

Dividend Yield

0%

Description

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

Contact

ONTARIO
Mississauga
1660 Tech Avenue, Unit 5
+19055688400.0
www.covalon.com

IPO

2004-09-03

Employees

-

Officers

Executive Chairman
Mr. Amir Boloor CFA
Senior Vice President of Growth
Mr. Ronald Hebert
CEO & Director
Mr. Brent Ashton
Co-Founder, Chief Scientific Officer & VP
Dr. Valerio DiTizio
Interim Chief Financial Officer
Ms. Katie Martinovich
Senior Vice President of Operations
Ms. Kim Crooks
Show More
Vice President of Human Resources
Mr. Greg Leszczynski
President of Covalon Technologies AG Ltd.
Gerry Arambula
Vice President of Business Development
Mr. Hamed Abbasian
Executive Assistant to the CEO
Emily Hill
Show Less

See Also

Discover More
What is the Intrinsic Value of one COV stock?

The intrinsic value of one COV stock under the Base Case scenario is 1.64 CAD.

Is COV stock undervalued or overvalued?

Compared to the current market price of 3.63 CAD, Covalon Technologies Ltd is Overvalued by 55%.

Back to Top